<DOC>
	<DOCNO>NCT00478751</DOCNO>
	<brief_summary>- Determine impact threshold long wavelength UVA visible light immediate delay pigment production melanocompetent individual . - The study basically want understand type light make u tan .</brief_summary>
	<brief_title>Impact Long Wavelength Ultraviolet ( UVA ) Visible Light Melanocompetent Skin</brief_title>
	<detailed_description>1 . Background : - A great deal know impact UVB short wavelength UVA pigmentation . Most sunscreens protect UVB portion UVA . However , clear component spectrum sunlight , currently protect sunscreen , capable elicit pigmentation . Very little known impact long wavelength UVA visible light time course pigmentation , quality pigmentation duration change pigment . This implication use sunscreens inhibit pigment production treatment condition aggravate sun exposure melasma . - The impact visible light ( 400-700 nm ) melanogenesis study Porges et al 1988 . The threshold dose IPD visible light 40 80 J/cm2 , threshold dose `` persistent '' pigmentation great equal 80 J/cm2 ( 1 ) . 2 . Study objective : -To determine impact long wavelength UVA visible light immediate delay pigment production melanocompetent individual . 3 . Study design : - Patient serve control . Patient must melanocompetent ( skin phototypes IV VI ) history vitiligo , melasma photosensitivity . The symmetric back forearm use control irradiated area . Two phototherapy delivery system develop study : 1 ) A target visible light phototherapy device , 2 ) A target long wavelength UVA device . - Pigmentation assess visual exam , fluorescent reflectance spectroscopy 6 timepoints : immediately irradiation , 30 minute exposure , 1 hour exposure , 1 day exposure , 1 week exposure 2 week exposure .</detailed_description>
	<criteria>For inclusion , subject must : 1 . Be least 18 year old ; 2 . Be healthy volunteer Fitzpatrick Skin phototypes IVVI base scale : Burns minimally , tan easily , average exposure Rarely burn , tan easily substantially Never burn tan profusely 3 . Agree abide Investigator 's guideline regard photosensitize drug photoprotection ; 4 . Be able understand requirement study , risk involve , able sign inform consent form ; 5 . Agree follow undergo studyrelated procedure . Subjects exclude follow apply : 1 . Women lactate , pregnant , plan become pregnant . 2 . Patients recent history vitiligo , melasma , disorder pigmentation exception post inflammatory hyperpigmentation . 3 . Patients known history photosensitivity disorder . 4 . Photosensitizing medication may continue throughout study discretion investigator ( appendix A ) . 5 . Patients known history melanoma nonmelanoma skin cancer 6 . Concomitant use tan bed . 7 . Sun exposure irradiate control area . 8 . Any reason investigator feel patient participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Visible light , Long UVA , Pigmentation</keyword>
	<keyword>Normal healthy volunteer dark skin type .</keyword>
</DOC>